Table 3.
Estimated hazard ratios (HRs) for OS and DFS-multivariate analysis
| Overall survival | Disease-free survival | |||
|---|---|---|---|---|
|
|
|
|||
| HR | p-value | HR | p-value | |
| Molecular subgroup | 0.450 | 0.277 | ||
| LUMA vs other | 0.646 | 0.552 | 0.878 | 0.844 |
| LUMB vs other | 0.236 | 0.201 | 0.227 | 0.188 |
| TNP vs other | 0.722 | 0.599 | 0.735 | 0.620 |
| HER2 vs other | 1.374 | 0.586 | 1.714 | 0.346 |
| LVI | 2.073 | 0.202 | 1.127 | 0.797 |
| Present vs absent | ||||
| NPI | 1.027 | 0.973 | 0.941 | 0.934 |
| Poor vs other | ||||
| Histologic Grade | 1.853 | 0.263 | 2.037 | 0.158 |
| III vs other | ||||
| Lymph node status | 1.986 | 0.356 | 2.507 | 0.220 |
| >3 vs 0-3 nodes | ||||
| Risk group | 2.231 | 0.245 | 1.747 | 0.399 |
| High vs other | ||||
| TNM | 0.873 | 0.804 | 0.771 | 0.636 |
| III vs other | ||||